CG Oncology’s late-stage bladder cancer treatment notched a complete response in roughly three-quarters of treated patients, fueling optimism that the company’s Wall Street success story is no fluke.

Return on Assets (ROA): CG Oncology's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of -6.12%, the company may face hurdles in generating ...

Studio Orange first opened its doors in 2004, spending decades creating some major additions to the anime world. In recent years, Orange has worked on projects including Trigun Stampede, Land of The ...

In a move that will be seized on as a sign that the IPO window is reopening in 2023, CG Oncology has not only become the first biotech to go public this year but overshot its own estimates. The ...

When bladder cancer does not respond to the current standard of care therapy, the next treatment option is surgery to completely remove the bladder. CG Oncology aims to give patients another choice.

PIVOT-006 Phase 3 topline data evaluating cretostimogene monotherapy as an adjuvant therapy in intermediate-risk NMIBC expected first half 2026CORE-008 Cohort CX Phase 2 first results of combination ...

When it comes to golf club technology, the term “center of gravity” — “CG” or “CoG” for short — gets thrown around quite a bit, but it isn’t often explained to the average golf consumer. While CG may ...

Communications firm CG Life rolled out a brand refresh Wednesday morning to highlight its commitment to science. The Shaped by Science rebrand seeks to underscore the inspiration behind the agency’s ...